Sage Investigational Site — Philadelphia, Pennsylvania

Sage Investigational Site is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Sage Investigational Site has participated in 12 clinical trials.

Therapeutic areas: Super-refractory Status Epilepticus, Huntington Disease, Super-Refractory Status Epilepticus.

Sponsors: Supernus Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sage Investigational Site?

Sage Investigational Site has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sage Investigational Site conducted?

Sage Investigational Site has 12 clinical trials on record. Their work covers Super-refractory Status Epilepticus, Huntington Disease, Super-Refractory Status Epilepticus.

Is Sage Investigational Site accredited by Crixeo Health?

Sage Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sage Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.